Please provide your email address to receive an email when new articles are posted on . The development of the Xpert MTB/RIF assay has been the most important breakthrough for the diagnosis of ...

Lack of access to molecular testing in regions with high tuberculosis burden can slow diagnosis and treatment. The ...

Tuberculosis (TB) causes more deaths globally than any other infectious disease and is a top 10 cause of death worldwide. Globally in 2017, of the estimated 10 million people with TB, 3.6 million were ...

Please provide your email address to receive an email when new articles are posted on . An updated version of the Xpert MTB/RIF assay, which includes new gene target ...

Tuberculosis (TB) causes more deaths globally than any other infectious disease and is a top 10 cause of death worldwide. Globally in 2017, of the estimated 10 million people with TB, 3.6 million were ...

In low-incidence, high-resource settings, Xpert Mycobacterium Tuberculosis/Rifampicin Ultra (Xpert MTB/RIF Ultra [Xpert-Ultra]) testing, an automated nucleic acid ...

Washington, DC - Aug. 29, 2017 - Researchers have demonstrated a new, improved version of the Xpert MTB/RIF assay, a test for Rifampicin-resistance (RIF-R). The Xpert "Ultra" assay overcomes the ...

Cepheid has supported TB testing worldwide for over 15 years. Xpert MTB/RIF, released in 2009 in collaboration with the Foundation for Innovative New Diagnostics (FIND), was a first-of-its-kind ...

The Xpert MTB/Ultra molecular diagnostic test for stool samples, until now recommended only for children, could be established as an additional test for diagnosing tuberculosis in adults living with ...

The World Health Organization (WHO) has granted prequalification to the molecular diagnostic test for tuberculosis (TB) called Xpert MTB/RIF Ultra. It is the first test for TB diagnosis and antibiotic ...